Rami Akhrass, MD
Additional Locations
Thoracic and Cardiovascular Surgery
Hillcrest Hospital
6770 Mayfield Road
Mayfield Heights, OH 44124
Directions
- Appointment:
- 440.449.9300
- Desk:
- 440.449.9300
- Fax:
- 440.778.3062
Thoracic and Cardiovascular Surgery
MetroHealth Medical Center (Hamann Bldg CT Surg)
2500 MetroHealth Drive
Cleveland, OH 44109
Directions
- Appointment:
- 216.778.5461
- Desk:
- 216.778.5461
- Fax:
- 216.778.3062
Treatment & Services
- Adult Cardiothoracic Surgery
- Cardiac Surgery
- Cardiovascular Surgery Department
- Coronary Artery Bypass Graft (CABG) Surgery
- Heart Surgery
- Regional Heart and Vascular
- Surgical Treatment of Adult Acquired Heart Disease
Specialty in Diseases & Conditions
- Acquired Adult Cardiac Disease
- Acquired Valve Disease
- Aortic Dissection
- Heart Disease
- Valve Disease
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Rami Akhrass, MD
Rami Akhrass, MD, is a Staff Cardiothoracic Surgeon with Cleveland Clinic. He is the Regional Medical Director of the Cardiothoracic Surgery Program. Dr. Akhrass specializes in the surgical treatment of adult acquired heart disease, including coronary revascularization, valve repair and replacement, and aortic and pulmonary surgery. He is certified by the American Board of Thoracic Surgery and the American Board of General Surgery.
A native of California with roots in Syria, Dr. Akhrass received his medical degree from Damascus University in Damascus, Syria. He did his internship in general surgery at the University of Hawaii in Honolulu prior to completing residencies in general surgery and cardiothoracic surgery at Case Western Reserve University in Cleveland. In 1997, Cleveland Clinic's Department of Thoracic and Cardiovascular Surgery awarded him a fellowship in adult cardiac surgery. Dr. Akhrass was appointed to Cleveland Clinic as a Staff Cardiothoracic Surgeon in 1998.
Dr. Akhrass has been an invited lecturer at international conferences on cardiothoracic surgical topics such as mitral valve repair, the durability of combined aortic and mitral valve repair, thoracic trauma and off-pump coronary revascularization. He is a Co-Investigator on a multicenter study of the safety of the EMBOL-X arterial cannula and filter system in patients undergoing coronary bypass grafting procedures requiring cardiopulmonary bypass. He has published in professional journals such as the Journal of Thoracic and Cardiovascular Surgery, PACE and American Surgeon.
Dr. Akhrass is a Fellow of the American College of Surgeons, a Fellow of the College of Chest Physicians and a member of the International Society for Heart and Lung Transplantation.
Education & Professional Highlights
Appointed
1998
Education & Fellowships
Fellowship - University Hospitals of Cleveland
Cardiothoracic Surgery
Cleveland,
OH
1997
Fellowship - Cleveland Clinic
Thoracic & Cardiovascular Surg
Cleveland,
OH United States
1997
Residency - University Hospitals of Cleveland
General Surgery
Cleveland,
OH
1995
Internship - University of Hawaii
Surgery
Honolulu,
HI
1990
Medical Education - Damascus University
MD
Damascus, Syria,
Syria
1987
Undergraduate - Damascus University
Damascus, Syria,
1983
Certifications
- Thoracic Surgery - Thoracic and Cardiac Surgery
Specialty Interests
Adult cardiothoracic surgery, aorta surgery, coronary artery bypass graft surgery, heart valve surgery, lung surgery, minimally invasive thoracic procedures, surgical ablation of atrial fibrillation, surgical treatment of adult acquired heart disease
Research & Publications
See publications for Rami Akhrass, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/17/2024, Dr. Akhrass has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
39 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
Overall | Star Ratings | |
---|---|---|
Explains | 4.7 | |
Listens | 4.9 | |
Courtesy, Respect & Concern | 4.8 | |
Patient Rating of Doctor | 4.8 |
2 Patient Comments
© 2024 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on Aug 29, 2024
Dr. Akhrass was very thorough in his description of what needed to be done. I felt very comfortable moving forward with him.
Reviewed on Apr 22, 2024
Attentive doctors explained everything clearly.